{"id":"https://openalex.org/W48883146","doi":null,"title":"Clinical effects of L-5-hydroxytryptophan administration in chronic schizophrenic patients.","display_name":"Clinical effects of L-5-hydroxytryptophan administration in chronic schizophrenic patients.","alternate_titles":[],"publication_year":1979,"publication_date":"1979-02-01","ids":{"openalex":"https://openalex.org/W48883146","mag":"48883146","pmid":"https://pubmed.ncbi.nlm.nih.gov/369623"},"language":"en","primary_location":{"id":"pmid:369623","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/369623","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biological psychiatry","raw_type":"Clinical Trial"},"parent_works":[],"lineage":["https://openalex.org/W48883146"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5108888132","display_name":"Llewellyn B. Bigelow","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"L B Bigelow","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076396157","display_name":"P Walls","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"P Walls","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110046266","display_name":"J. Christian Gillin","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J C Gillin","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":null,"display_name":"R J Wyatt","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"R J Wyatt","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.6699,"has_fulltext":false,"cited_by_count":25,"citation_normalized_percentile":{"value":0.66309486,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":95},"biblio":{"volume":"14","issue":"1","first_page":"53","last_page":"67"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9922000169754028,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9922000169754028,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.0035000001080334187,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11337","display_name":"Tryptophan and brain disorders","score":0.00279999990016222,"subfield":{"id":"https://openalex.org/subfields/2803","display_name":"Biological Psychiatry"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/5-hydroxy-l-tryptophan","display_name":"L-5-hydroxytryptophan","score":0.9959999918937683},{"id":"https://openalex.org/keywords/chronic-schizophrenia","display_name":"chronic schizophrenia","score":0.9150000214576721},{"id":"https://openalex.org/keywords/carbidopa","display_name":"carbidopa","score":0.8240000009536743},{"id":"https://openalex.org/keywords/neuroleptic-withdrawal","display_name":"neuroleptic withdrawal","score":0.8610000014305115},{"id":"https://openalex.org/keywords/haloperidol","display_name":"haloperidol","score":0.9670000076293945},{"id":"https://openalex.org/keywords/chlorpromazine","display_name":"chlorpromazine","score":1.0},{"id":"https://openalex.org/keywords/psychosis-exacerbation","display_name":"psychosis exacerbation","score":0.8199999928474426},{"id":"https://openalex.org/keywords/serotonin-precursor","display_name":"serotonin precursor","score":0.6060000061988831},{"id":"https://openalex.org/keywords/placebo-controlled-crossover-trial","display_name":"placebo-controlled crossover trial","score":0.7749999761581421}],"concepts":[{"id":"https://openalex.org/C2778775820","wikidata":"https://www.wikidata.org/wiki/Q407972","display_name":"Chlorpromazine","level":2,"score":0.7867646217346191},{"id":"https://openalex.org/C2780948584","wikidata":"https://www.wikidata.org/wiki/Q251347","display_name":"Haloperidol","level":3,"score":0.7508624196052551},{"id":"https://openalex.org/C2776754145","wikidata":"https://www.wikidata.org/wiki/Q71133637","display_name":"Carbidopa","level":5,"score":0.5905633568763733},{"id":"https://openalex.org/C2779399491","wikidata":"https://www.wikidata.org/wiki/Q238544","display_name":"5-Hydroxytryptophan","level":4,"score":0.5862653851509094},{"id":"https://openalex.org/C37000724","wikidata":"https://www.wikidata.org/wiki/Q50430226","display_name":"Serotonergic","level":4,"score":0.583949863910675},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.579146146774292},{"id":"https://openalex.org/C2779727114","wikidata":"https://www.wikidata.org/wiki/Q170082","display_name":"Psychosis","level":2,"score":0.5785544514656067},{"id":"https://openalex.org/C2908591018","wikidata":"https://www.wikidata.org/wiki/Q4795512","display_name":"Decarboxylase inhibitor","level":5,"score":0.5480556488037109},{"id":"https://openalex.org/C2775864247","wikidata":"https://www.wikidata.org/wiki/Q167934","display_name":"Serotonin","level":3,"score":0.5440049767494202},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.472215473651886},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.43709009885787964},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.4013557434082031},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.32760298252105713},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.2697668671607971},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.168366938829422},{"id":"https://openalex.org/C2780304432","wikidata":"https://www.wikidata.org/wiki/Q300989","display_name":"Levodopa","level":4,"score":0.13301721215248108},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.05744296312332153},{"id":"https://openalex.org/C2779734285","wikidata":"https://www.wikidata.org/wiki/Q11085","display_name":"Parkinson's disease","level":3,"score":0.0},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002230","descriptor_name":"Carbidopa","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D002746","descriptor_name":"Chlorpromazine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D002908","descriptor_name":"Chronic Disease","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006220","descriptor_name":"Haloperidol","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006916","descriptor_name":"5-Hydroxytryptophan","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012559","descriptor_name":"Schizophrenia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true}],"locations_count":2,"locations":[{"id":"pmid:369623","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/369623","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biological psychiatry","raw_type":"Clinical Trial"},{"id":"mag:48883146","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/369623","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2049811384","https://openalex.org/W1965948172","https://openalex.org/W2091942717","https://openalex.org/W1993381750","https://openalex.org/W163533325","https://openalex.org/W136199024","https://openalex.org/W2470745651","https://openalex.org/W1985613550","https://openalex.org/W1952785760","https://openalex.org/W2077208907"],"abstract_inverted_index":{"L-5-Hydroxytryptophan":[0],"(L-5HTP)":[1],"and":[2,98],"the":[3,61,77,89,113,118,142],"peripheral":[4],"decarboxylase":[5],"inhibitor":[6],"carbidopa":[7],"were":[8,63,68],"administered":[9],"to":[10,31,45,54,93,108,117,141,149],"chronic":[11],"schizophrenic":[12,145],"patients":[13,33,47,56],"in":[14,81,88,101,164],"three":[15,25],"separate":[16],"experiments":[17,26],"using":[18],"a":[19,75,150,161],"double-blind":[20],"placebo-controlled":[21],"crossover":[22],"design.":[23],"The":[24],"were:":[27],"(i)":[28],"L-5HTP":[29,43,52,107,121,129],"administration":[30,44,53],"15":[32],"who":[34],"had":[35],"been":[36],"withdrawn":[37],"from":[38],"all":[39],"neuroleptic":[40,96],"medication;":[41],"(ii)":[42],"seven":[46],"maintained":[48,57],"on":[49,58],"haloperidol;":[50],"(iii)":[51],"nine":[55],"chlorpromazine.":[59,109],"Although":[60],"groups":[62],"diagnostically":[64],"homogeneous,":[65],"individual":[66],"responses":[67],"highly":[69],"variable.":[70],"Considering":[71],"each":[72],"group":[73,91],"as":[74],"whole,":[76],"only":[78],"significant":[79],"changes":[80],"rated":[82],"psychosis":[83,102,126],"consisted":[84],"of":[85,120,125,152],"an":[86,99],"increase":[87,100],"first":[90],"consequent":[92,148],"coming":[94],"off":[95],"medication":[97],"scores":[103],"associated":[104],"with":[105],"adding":[106],"Neuroleptics":[110],"apparently":[111],"sensitize":[112],"central":[114],"nervous":[115],"system":[116],"effects":[119],"loading.":[122],"Acute":[123],"exacerbations":[124],"induced":[127],"by":[128,133,159],"can":[130,156],"be":[131,157],"reversed":[132],"neuroleptics.":[134],"Our":[135],"experience":[136],"does":[137],"not":[138],"give":[139],"encouragement":[140],"hypothesis":[143],"that":[144,155],"illnesses":[146],"arise":[147],"deficit":[151],"serotonergic":[153],"function":[154],"treated":[158],"giving":[160],"serotonin":[162],"precursor":[163],"pharmacological":[165],"quantities.":[166]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W48883146","counts_by_year":[{"year":2021,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
